In topical and transdermal product development, time and cost are the biggest constraints, and poor formulation design is often the hidden cause of both. Across the pharmaceutical industry, late-stage reformulation is among the most expensive mistakes R&D teams make. Each adjustment to the composition, process, or stability profile triggers new analytical, IVRT/IVPT, and bioequivalence studies, […]